spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 26 September 2007
doi: 10.1242/dev.008250


Development 134, 3929-3939 (2007)
Published by The Company of Biologists 2007


This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roarty, K.
Right arrow Articles by Serra, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roarty, K.
Right arrow Articles by Serra, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Wnt5a is required for proper mammary gland development and TGF-ß-mediated inhibition of ductal growth

Kevin Roarty and Rosa Serra*

Department of Cell Biology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.


Figure 1
View larger version (57K):
[in this window]
[in a new window]

 
Fig. 1. TGF-ß regulates Wnt5a expression in mice. (A) Semiquantitative RT-PCR of Wnt5a cDNA from wild-type and DNIIR mammary glands, illustrating reduced expression of Wnt5a mRNA in DNIIR glands relative to wild-type control glands. 18S was used to normalize for the amount of total RNA. PCR product is shown in the linear range (22 cycles for Wnt5a and 15 cycles for 18S). Wild-type and DNIIR labels represent mammary glands from individual mice administered ZnSO4 for 2 weeks to induce DNIIR transgene expression. (B) Wnt5a and HGF protein levels in wild-type and DNIIR mammary glands depicted by western blot show reduced Wnt5a protein levels in DNIIR glands and elevated HGF levels. Wild-type and DNIIR labels represent mammary glands from separate mice. ß-Tubulin was used to normalize for the amount of protein loaded. (C-F) Primary epithelial cells and fibroblasts isolated from 8-week-old adult virgin Balb/c mice were cultured and treated with TGF-ß1. Treatment resulted in an induction of Wnt5a mRNA as measured by semiquantitative RT-PCR in both primary epithelial cells (C) and primary fibroblasts (D). Induction of Wnt5a was also seen at the protein level in both cell types (E,F). Vimentin expression was used as a marker for fibroblasts. (G,H) Mammary epithelial cells (G) and fibroblasts (H) were untreated (-) or pretreated (+) with cycloheximide followed by treatment with vehicle (-) or TGF-ß1 for 12 hours (+), at which time RNA was extracted from the cells. The level of Wnt5a mRNA was determined by semi-quantitative RT-PCR. Treatment with TGF-ß in the presence of cycloheximide resulted in an increase in Wnt5a mRNA, suggesting that TGF-ß stimulates Wnt5a expression even in the absence of new protein synthesis.

 

Figure 2
View larger version (105K):
[in this window]
[in a new window]

 
Fig. 2. Wnt5a inhibits ductal extension accompanied by diminished terminal end bud size and proliferation. (A) A representative whole-mount image of a #4 inguinal mammary gland with BSA pellet (P) depicts normal ductal extension through the fat pad. Horizontal arrow represents the distance from the lymph node to the end of the TEB. (B) A whole-mount image of the gland contralateral to the one shown in A illustrates the inhibition of ductal extension through the fat pad by Wnt5a pellet (P). (C) Quantification of ductal inhibition from 11 mice using a paired Student's t-test demonstrates that the inhibition is statistically significant (P<0.05). (D) Magnification of the terminal end bud size from control glands in A depicts the normal size of the end buds during puberty. (E) Magnification of the end buds in B demonstrates the smaller size of the end buds after Wnt5a exposure. (F,G) H&E staining of the terminal end buds from the BSA (F) and Wnt5a (G) groups illustrates the reduction in size of the terminal end buds with Wnt5a. (H) BrdU incorporation in the end bud. Exposure to Wnt5a resulted in a fourfold decrease in proliferation in the terminal end buds. Significance was determined by a Student's t-test (P<0.05). Representative images are shown to the right of the graph. (I) There was no statistically significant difference in apoptosis within the terminal end buds, determined by TUNEL staining.

 

Figure 3
View larger version (46K):
[in this window]
[in a new window]

 
Fig. 3. Wnt5a inhibits lateral branching in vivo and HGF-induced branching morphogenesis in vitro. (A-C) Wnt5a inhibits lateral branching in vivo. Carmine staining of murine mammary glands treated with slow-release pellets containing BSA (A) or Wnt5a in the contralateral gland (B). The pellet is marked. (C) The average number of secondary branches per 0.5 cm of the primary branch was calculated from three separate fields for each gland. Error bars represent the standard deviation of the average from the three fields. A paired Student's t-test indicated that the differences were significant. (D-G) Wnt5a inhibits branching and growth in mammary organoids in culture. Phase contrast images showing primary mammary organoids untreated or treated with HGF alone or in combination with Wnt5a (D). Quantification of primary branch number demonstrates a statistically significant reduction in branching in cultures treated with Wnt5a compared to HGF alone, determined by a Student's t-test (E; P<0.05). Quantification of primary branch length shows that Wnt5a inhibited the extent of branching from the organoids, (F; P<0.05). Organoids treated with Wnt5a showed a statistically significant reduction in proliferation as determined by BrdU incorporation (G; P<0.05), illustrated to the right.

 

Figure 4
View larger version (95K):
[in this window]
[in a new window]

 
Fig. 4. Absence of Wnt5a accelerates mammary development in mice. (A) Carmine-stained whole-mount #1 gland from E18.5 wild-type and Wnt5a-/- mice. (B) Carmine-stained mammary tissue that was grafted under the kidney capsule of 3-week-old ICR/SCID mice demonstrates accelerated development in Wnt5a-/- tissue compared with wild-type tissue after 1 week. Increased ductal invasion, extensive branching and larger terminal end buds were noted in the Wnt5a-/- tissue (arrowheads). (C) Brdu analysis of mammary tissue transplanted under the kidney capsule demonstrates a twofold increase in proliferation of Wnt5a-/- mammary tissue compared with wild type (P=0.0005). (D,E) Whole-mount staining of mammary tissue inserted into cleared fat pads of 3-week-old ICR/SCID hosts shows accelerated mammary development of Wnt5a-/- epithelium (E) compared with wild-type epithelium (D) after 2 weeks of development. Arrowheads indicate terminal end buds (TEBs).

 

Figure 5
View larger version (52K):
[in this window]
[in a new window]

 
Fig. 5. TGF-ß activates discoidin domain receptor 1 via upregulation of Wnt5a in mice. (A) Immunoprecipitation of Ddr1 from protein lysate of DNIIR and wild-type mammary glands and western blotting for phosphotyrosine demonstrates diminished Ddr1 tyrosine phosphorylation in DNIIR glands compared with wild-type glands. (B) Primary epithelial cells cultured on type I collagen were treated with Wnt5a. Immunoprecipitation of Ddr1 and western blotting for phosphotyrosine shows an increase in Ddr1 phosphorylation within 30 minutes of Wnt5a treatment. (C) Western blots show TGF-ß1 is able to induce Ddr1 phosphorylation in primary epithelial cells after 30 hours, following induction of Wnt5a protein levels seen at 24 hours. (D) IP western blotting illustrates Wnt5a-/- epithelial cells cultured on type I collagen were unable to undergo Ddr1 phosphorylation in response to TGF-ß1 treatment.

 

Figure 6
View larger version (65K):
[in this window]
[in a new window]

 
Fig. 6. In mice, TGF-ß1 is unable to inhibit ductal growth of Wnt5a-/- epithelium in vivo and branching of Wnt5a-/- organoids in vitro. (A) Carmine-stained BSA-treated and the contralateral TGF-ß-treated wild-type mammary gland confirms that the TGF-ß1 pellets (P) are functional and result in degeneration of the end bud and inhibition of ductal elongation. Insets represent magnified images of the end buds. (B) Carmine-stained glands reconstituted with Wnt5a-/- epithelium. The left gland was treated with BSA and the right contralateral gland was treated with TGF-ß1. TGF-ß is unable to inhibit the end bud in the absence of Wnt5a. Insets represent magnified images of the end buds. (C) Ki67 staining in the end buds of wild-type mice either treated with BSA or TGF-ß. Treatment with TGF-ß resulted in reduced staining relative to BSA-treated glands. (D) Ki67 staining in the end buds of Wnt5a-/- reconstituted glands treated with BSA or TGF-ß. Staining was similar in BSA- and TGF-ß-treated end buds. (E) Phase contrast images of wild-type mammary organoid preparations untreated or treated with HGF or HGF and TGF-ß1 shows TGF-ß-mediated inhibition of HGF-induced branching. Three representative images are shown for each condition. (F) Wnt5a-/- organoids were untreated or treated with HGF or TGF-ß and HGF. Untreated Wnt5a-/- cultures demonstrated increased branching relative to wild-type cultures. TGF-ß failed to inhibit branching in the absence of Wnt5a. Three representative images are shown for each condition. (G) Primary branching was quantified in wild-type and Wnt5a-/- cultures untreated or treated with HGF or TGF-ß and HGF. In wild-type cultures treatment with TGF-ß resulted in a statistically significant decrease in branching. TGF-ß did not inhibit branching in Wnt5a-/- cultures.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2007